期刊文献+

涎腺黏液表皮样癌中Cox-2、EZH2的表达及意义 被引量:2

Expression of Cox-2 and EZH2 in mucoepidermoid carcinoma of salivary glands
下载PDF
导出
摘要 【目的】研究Cox-2和EZH2在涎腺黏液表皮样癌(MEC)中的表达和意义。【方法】应用免疫组化PV-6001二步法检测34例MEC、11例正常涎腺组织(NSG)中Cox-2、EZH2的表达,采用SPSS16.0软件进行统计学分析。【结果】Cox-2与EZH2在MEC中的表达明显高于NSG,差异有统计学意义(P<0.01);Cox-2在MEC高、中、低分化、复发及转移中的表达差异有统计学意义(P<0.05,P<0.01);EZH2在MEC高、中与低分化、部位、复发、转移中的表达差异亦有统计学意义(P<0.01,P<0.05);两者在MEC中的表达呈正相关(rs=0.680,P<0.01)。【结论】Cox-2、EZH2在MEC中高表达,且与MEC病理分型及复发、转移密切相关;EZH2的表达还与MEC的发生部位有关;联合检测Cox-2和EZH2有助于MEC的诊断、治疗及预后评估。 [Objective] To explore the expression of cyclooxygenase-2 (Cox-2) and its enhancer of zester homologne (EZH2) in mucoepidermoid carcinoma (MEC). [Methods] PV-6001 two-step immunohistochemical assay was used to test the expression of Cox-2 and EZH2 in 34 cases of MEC and 11 cases of normal salivary gland tissue (NSG), and SPSS16.0 software was used for statistical analysis. [Results] The expression level of Cox-2 and EZH2 in the MEC was significantly higher than that in the NSG group (P 〈 0.01). Cox-2 expressed the high, middle and low differentiated group and recurrent group and metastasized tissue (P 〈 0.05, P 〈 0.01). There was statistical difference of the expression of EZH2 not only among the high, middle and low differentiated group but also in localization and recurrence and metastasis of MEC (P 〈 0.01, P 〈 0.05). The expression of Cox-2 and EZH2 in MEC was positively correlated (rs = 0.680, P 〈 0.01). [Conclusions] It is suggested that Cox-2 and EZH2 expressed in MEC related to its localization, recurrence and metastasis. The expression of EZH2 might be related with the localization of MEC. And the examination of Cox-2 combined with EZH2 in the MEC might be a useful approach for determining its diagnosis, management and prognosis.
出处 《武警医学院学报》 CAS 2012年第7期506-508,512,F0004,共5页 Acta Academiae Medicinae CPAPF
关键词 涎腺 黏液表皮样癌 免疫组织化学 环氧合酶-2 EZH2 Salivary Mucoepidermoid carcinoma Immunohistochemistry Cyclooxygenase-2 EZH2
  • 相关文献

参考文献14

  • 1Chenevert J, Barnes LE, Chiosea SI. Virchows Arch..Mucoe- pidermoid carcinoma: a five-decade journey[J]. 2011,458(2): 133-140.
  • 2Lopes MA, Cruz Perez DE, Abrea Alves F, et al. Clinic- pathologic and immunohistochemical study of intraoral mucoepidermoid carcinoma [J]. Otolaryngol Head Neck Surg, 2006, 134(4): 622-626.
  • 3高雪芹,张维东.COX-2在肿瘤组织的表达及其化学预防靶点的意义[J].中国公共卫生,2002,18(2):249-250. 被引量:10
  • 4劳均平,陈巨峰.转化生长因子β1及Ki-67核抗原在涎腺黏液表皮样癌中的表达和意义[J].中华口腔医学杂志,2011,46(1):20-23. 被引量:1
  • 5Yang H, Chen C. Cyclooxygenase-2 in synaptic signaling[J]. Curr Pharm Des, 2008, ld: 1443-1451.
  • 6赵臣勇,何卿玮,王发祥,万金城,周长青,彭国光,张江伟.优化核酸疫苗对帕金森模型小鼠黑质COX-2表达的影响[J].解放军医学杂志,2011,36(3):244-248. 被引量:6
  • 7Ristim~iki A, Sivula A, Lundin J, et al. Prognostic signific- ance of elevated cyclooxygenase-2 expression in breast cancer[J]. Cancer Res, 2002, 62: 632-635.
  • 8Pandey M, Prakash O, Santhi WS, et al. Over expression of Cox-2 gene in oral cancer is independent of stage of disease and degree of differen- tiation [J]. Int J Oral Maxillofac Surg, 2008, 37:379-383.
  • 9Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer [J]. Nature, 2002, 419(6907):624-9.
  • 10Bachmann IM, Halvorsen OJ, Collett K, eta/. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate and breast[J]. J Clin Oncol, 2006, 24(2):268-273.

二级参考文献49

  • 1何卿玮,王加才,彭国光,王法祥.pVAX1-IL-4/SYN-B融合质粒的构建及表达[J].免疫学杂志,2009,25(5):588-590. 被引量:8
  • 2彭燕,陈海滨.EZH2基因在肿瘤演进中的研究进展[J].汕头大学医学院学报,2004,17(4):254-256. 被引量:4
  • 3金行藻,黄文斌.前列腺腺癌的病理特征和分级[J].临床与实验病理学杂志,2005,21(2):131-136. 被引量:11
  • 4Kononen J, Bubendorf L. Tissue micoarray for high-throughput molecular profiling of tumor specimens [ J 1. Nat Med, 1998,4 ( 7 ) : 844 - 847.
  • 5Hobert O, Jallal B, Ullrieh A. Interaction of vav with ENX-1 ,a putative transcriptional regulator of homeobox gene expression [ J ]. MCB,1996,16(6) :3066.
  • 6Varambally S, Dhanasekaran S M, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer [ J ]. Nature,2002, 419 ( 6907 ) :624.
  • 7Tang X, Milyavsky M, Shats I,et al. Activated p53 suppresses the historic methyhransferase EZH2 gene [ J ]. Oncogene, 2004, 23 (34) :5759 -5769.
  • 8Kleer C G,Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells[ J]. PNAS ,2003,100(20 ) : 11606 - 11611.
  • 9Bracken A P,Pasini D, Capra M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer[J]. EMBO J,2003,22(20) :5323 -5335.
  • 10Zetter B R, Banyard J. Cancer: The silenee of the genes[ J]. Nature ,2002,419 ( 6907 ) :572 - 573.

共引文献18

同被引文献57

  • 1刘晋,于皆平,王晓玲,周晓东,于红刚.环氧合酶-2和血管内皮生长因子-C与胃癌淋巴管转移[J].中华内科杂志,2004,43(11):841-844. 被引量:13
  • 2王旭,王洁,董福生,董玉英,侯亚丽.COX-2及survivin在涎腺多形性腺瘤中表达的定量研究[J].山东医药,2005,45(12):1-2. 被引量:4
  • 3GHANEH P, GREENHALF W, HUMPHREYS M, et al. Adenovirusmediated transfer of p53 and p16 (INK4a) results in pancreatic cancer re~ression in vitro and in vivo[J]. Gene Ther, 2001, 8: 199-208.
  • 4DUFFY M J, O'DONOVGHUA N, BRENNAN D J, et al. survivin: a promising tumor biomarker[J]. Cancer lett, 2007, 249(1): 49-60.
  • 5KESAKA T, MIYATA Y, IHARA H, et al. Characterization of the human gene(PTGS2)encoding prostaglandin-endopemxide synthase 2 [J]. Eur J Bieehem, 1994, 221(3): 889-897.
  • 6MITA A C, MITA M M, NAWROCKI S T, et al. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics[J]. Clin Cancer Res, 2008, 14(16): 5000-5005.
  • 7OCONNOR D S, SCHCCHNER J S, ADIDA C, et al. Control of apoptmis during angiogeneses by survivin expression in endothelial cells[J]. Am J Pathol, 2000, 156(2): 393-398.
  • 8LIU X, KIRSCHENBUAM A, YAO S, et al. Up-regulation of Vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclcoxygenase-2 in a metastatic human prostate cancer cellines[J]. Clin Exp Metastasis, 1999, 17(8): 687-694.
  • 9GROSSMAN D, KIM P J, BLANC-BRUDE O P, et al. Transgenic expression of Survivin in keratinocytes counteracts UVB- induced apoptosis and cooperates with loss of p53[J]. Clin Invest, 2001, 108(7): 991.
  • 10DU BOIS R N, SHAO J, TSUJII M, et al. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2[J], tancer Kes, 1996, 56(4): 733--737.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部